dc.contributor.author |
Ugarte-Gil, Manuel Francisco |
|
dc.contributor.author |
Gamboa-Cardenas, Rocio Violeta |
|
dc.contributor.author |
Reátegui-Sokolova, Cristina |
|
dc.contributor.author |
Pimentel-Quiroz, Victor Román |
|
dc.contributor.author |
Medina, Mariela |
|
dc.contributor.author |
Elera-Fitzcarrald, Claudia |
|
dc.contributor.author |
Rodriguez-Bellido, Zoila |
|
dc.contributor.author |
Pastor-Asurza, Cesar Augusto |
|
dc.contributor.author |
Perich-Campos, Risto Alfredo |
|
dc.contributor.author |
Alarcón, Graciela S. |
|
dc.coverage.spatial |
Departamento de Reumatología, Hospital Guillermo Almenara Irigoyen, Lima, Peru. |
|
dc.date.accessioned |
2023-03-23T15:49:32Z |
|
dc.date.available |
2023-03-23T15:49:32Z |
|
dc.date.issued |
2023 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/13258 |
|
dc.description.abstract |
Objective To determine the possible predictive value of self-efficacy on health-related quality of life (HRQoL) in patients with SLE. Methods Patients with SLE from the Almenara Lupus Cohort were included. Self-efficacy was ascertained with the six domains from the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing chronic conditions. For PROMIS domains, a score of 50 is the average for a clinical population (people with a chronic condition), a higher score indicates that the respondent has greater self-efficacy. HRQoL was ascertained with the physical and mental component summary (PCS and MCS) measures of the Short-Form 36 (SF-36). Generalised estimating equations were performed, using as outcome the PCS or MCS in the subsequent visit, and the self-efficacy domain in the previous visit; multivariable models were adjusted for possible confounders. The confounders were measured in the same visit as the self-efficacy domain. Results Two-hundred and nine patients for a total of 564 visits were included; 194 (92.8%) patients were women and mean age at diagnosis was 36.4 (14.0) years. In the multivariable models, a better PCS was predicted by a better self-efficacy for managing symptoms, managing medications and treatments and managing social interactions and general self-efficacy; a better MCS was predicted by a better self-efficacy for managing daily activities, managing symptoms, managing medications and treatments and managing social interactions. Conclusion A better self-efficacy is predictive of subsequent better HRQoL, even after adjustment for possible confounders. These results should encourage clinicians to develop strategies to improve self-efficacy in patients with SLE. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
BMJ Publishing Group |
|
dc.relation.ispartofseries |
Lupus Science and Medicine |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
quality of life |
en_US |
dc.subject |
HRQoL |
en_US |
dc.subject |
patients |
en_US |
dc.subject |
systemic lupus erythematosus |
en_US |
dc.subject |
Almenara Lupus Cohort |
en_US |
dc.subject.mesh |
Calidad de Vida |
|
dc.subject.mesh |
Lupus Eritematoso Sistémico |
|
dc.title |
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: Data from the Almenara Lupus Cohort |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1136/lupus-2022-000874 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.03 |
|
dc.relation.issn |
2053-8790 |
|